TY - JOUR
T1 - Publication rates in English of abstracts presented at the annual meeting of the Japanese Society of Psychiatry and Neurology
AU - Yoshida, Kazunari
AU - Moriguchi, Sho
AU - Koda, Masahide
AU - Oka, Takuya
AU - Ueno, Fumihiko
AU - Ikai-Tani, Saeko
AU - Tani, Hideaki
AU - Mimura, Masaru
N1 - Funding Information:
KY has received manuscript fees from Sumitomo Dainippon Pharma, Azrieli Adult Neurodevelopmental Centre Postdoctoral Fellowship at CAMH and Discovery Fund 2021 Talent Development Competition: Postdoctoral Fellowship at CAMH, and consultant fees from MedAvante‐ProPhase Inc., Signant Health, and VeraSci within the past three years. SM has received a Grant‐in‐Aid for Scientific Research (B) (20H03606) from the Japan Society for the Promotion of Science (JSPS), medical research grant from Takeda Science Foundation. SI has received a grant from the Japan Society for the Promotion of Science, the Grant‐in‐Aid for Young Scientists, and manuscript fees or speaker's honoraria from Dainippon Sumitomo, and Wiley, Otsuka within the past 3 years. HT was supported by a fellowship from the Canadian Institutes of Health Research (CIHR) and the Japanese Society of Clinical Neuropsychopharmacology (JSCNP). He has received a research grant from Eli Lilly and received manuscript fees from Dainippon Sumitomo Pharma, Otsuka Pharmaceutical, Wiley Japan and Yoshitomi Yakuhin. MM has received speaker's honoraria from Byer Pharmaceutical, Daiichi Sankyo, Dainippon‐Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Hisamitsu Pharmaceutical, Janssen Pharmaceutical, Kyowa Pharmaceutical, Mochida Pharmaceutical, MSD, Mylan EPD, Nihon Medi‐physics, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Santen Pharmaceutical, Shire Japan, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin within the past 3 years. Also, he received grants from Daiichi Sankyo, Eisai, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi and Tsumura within the past 3 years outside the submitted work. The other authors have nothing to disclose.
Publisher Copyright:
© 2022 The Authors Psychiatry and Clinical Neurosciences © 2022 Japanese Society of Psychiatry and Neurology.
PY - 2022/6
Y1 - 2022/6
N2 - Background: Relatively low publication rates of abstracts presented at scientific meetings (i.e. 37.3%, 95% CI: 35.3–39.3) have been reported across various fields worldwide. However, no study has investigated the publication rate of abstracts presented at psychiatric meetings and factors associated with full publication in Japan. This study aimed to determine the proportion of conference abstracts in the psychiatric field that reach full publication in English and its associated factors in Japan. Methods: A retrospective study was conducted to determine the publication rate of abstracts presented at the annual meetings of the Japanese Society of Psychiatry and Neurology (JSPN) in 2013 and 2014, the largest psychiatric meeting in Japan, by searching for full-text publications in PubMed and Google Scholar. Furthermore, we examined factors associated with a successful full publication of the conference abstract. Results: Of the 737 abstracts evaluated, 132 (17.9%) were published in peer-reviewed journals; the publication rates for oral and poster presentations were 12.7% (46/363) and 23.0% (86/374), respectively. In multivariate logistic regression analyses, the following factors were significantly associated with successful publications: poster presentations (odds ratio [OR]: 1.67, 95% CI: 1.10–2.57), original studies (OR: 4.16, 95% CI: 2.44–7.47), and academic institutions (OR: 5.77, 95% CI: 3.44–10.19). Conclusions: The publication rate in English of the conference abstracts presented at the JSPN annual meetings was relatively lower than those in previous studies. Further encouragement of the publication of the abstracts presented in psychiatric conferences in Japan would be helpful in disseminating scientific findings in the field of psychiatry.
AB - Background: Relatively low publication rates of abstracts presented at scientific meetings (i.e. 37.3%, 95% CI: 35.3–39.3) have been reported across various fields worldwide. However, no study has investigated the publication rate of abstracts presented at psychiatric meetings and factors associated with full publication in Japan. This study aimed to determine the proportion of conference abstracts in the psychiatric field that reach full publication in English and its associated factors in Japan. Methods: A retrospective study was conducted to determine the publication rate of abstracts presented at the annual meetings of the Japanese Society of Psychiatry and Neurology (JSPN) in 2013 and 2014, the largest psychiatric meeting in Japan, by searching for full-text publications in PubMed and Google Scholar. Furthermore, we examined factors associated with a successful full publication of the conference abstract. Results: Of the 737 abstracts evaluated, 132 (17.9%) were published in peer-reviewed journals; the publication rates for oral and poster presentations were 12.7% (46/363) and 23.0% (86/374), respectively. In multivariate logistic regression analyses, the following factors were significantly associated with successful publications: poster presentations (odds ratio [OR]: 1.67, 95% CI: 1.10–2.57), original studies (OR: 4.16, 95% CI: 2.44–7.47), and academic institutions (OR: 5.77, 95% CI: 3.44–10.19). Conclusions: The publication rate in English of the conference abstracts presented at the JSPN annual meetings was relatively lower than those in previous studies. Further encouragement of the publication of the abstracts presented in psychiatric conferences in Japan would be helpful in disseminating scientific findings in the field of psychiatry.
KW - Japan
KW - abstracts
KW - psychiatry
KW - publication rate
UR - http://www.scopus.com/inward/record.url?scp=85128160268&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128160268&partnerID=8YFLogxK
U2 - 10.1111/pcn.13351
DO - 10.1111/pcn.13351
M3 - Article
C2 - 35294087
AN - SCOPUS:85128160268
SN - 1323-1316
VL - 76
SP - 206
EP - 211
JO - Psychiatry and Clinical Neurosciences
JF - Psychiatry and Clinical Neurosciences
IS - 6
ER -